ATLAS / Macro Radar / Reporting / BMRN

BIOMARIN PHARMACEUTICAL INC (BMRN) reporting calendar

BIOMARIN PHARMACEUTICAL INC files periodic reports with the SEC as BMRN on Nasdaq. Atlas tracks 39 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
21 Jul 2026 – 18 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
5 May 2026
Reports on record
39

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 35 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open BMRN market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20265 May 202635 days0001048477-26-000008
10-K31 Dec 202526 Feb 202657 days0001048477-26-000004
10-Q30 Sep 202528 Oct 202528 days0001048477-25-000107
10-Q30 Jun 20255 Aug 202536 days0001048477-25-000090
10-Q31 Mar 20252 May 202532 days0001048477-25-000051
10-K31 Dec 202424 Feb 202555 days0001048477-25-000007
10-Q30 Sep 202431 Oct 202431 days0001048477-24-000152
10-Q30 Jun 20245 Aug 202436 days0001048477-24-000126
10-Q31 Mar 202426 Apr 202426 days0001048477-24-000070
10-K31 Dec 202326 Feb 202457 days0001048477-24-000016
10-Q30 Sep 20232 Nov 202333 days0001048477-23-000044
10-Q30 Jun 20232 Aug 202333 days0001048477-23-000029
10-Q31 Mar 202328 Apr 202328 days0001048477-23-000020
10-K31 Dec 202227 Feb 202358 days0001048477-23-000009
10-Q30 Sep 202228 Oct 202228 days0001048477-22-000033
10-Q30 Jun 20224 Aug 202235 days0001048477-22-000027
10-Q31 Mar 202229 Apr 202229 days0001048477-22-000018
10-K31 Dec 202125 Feb 202256 days0001048477-22-000012
10-Q30 Sep 202129 Oct 202129 days0001048477-21-000032
10-Q30 Jun 202130 Jul 202130 days0001048477-21-000025
10-Q31 Mar 202130 Apr 202130 days0001048477-21-000016
10-K31 Dec 202026 Feb 202157 days0001048477-21-000008
10-Q30 Sep 20206 Nov 202037 days0001048477-20-000029
10-Q30 Jun 20205 Aug 202036 days0001048477-20-000023
10-Q31 Mar 20201 May 202031 days0001048477-20-000016
10-K31 Dec 201927 Feb 202058 days0001048477-20-000009
10-Q30 Sep 201929 Oct 201929 days0001048477-19-000015
10-Q30 Jun 20192 Aug 201933 days0001048477-19-000007
10-Q31 Mar 201929 Apr 201929 days0001564590-19-013461
10-K31 Dec 201828 Feb 201959 days0001564590-19-005033
10-Q30 Sep 201826 Oct 201826 days0001564590-18-025196
10-Q30 Jun 20183 Aug 201834 days0001564590-18-019022
10-Q31 Mar 201827 Apr 201827 days0001564590-18-009416
10-K31 Dec 201726 Feb 201857 days0001564590-18-003114
10-Q30 Sep 201731 Oct 201731 days0001564590-17-020527
10-Q30 Jun 20172 Aug 201733 days0001564590-17-014975
10-Q31 Mar 20174 May 201734 days0001564590-17-008822
10-K31 Dec 201627 Feb 201758 days0001564590-17-002483
10-Q30 Sep 20163 Nov 201634 days0001564590-16-027187

Source: SEC EDGAR company submissions for CIK 0001048477. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.